Cereona Partners provides capital formation and strategic advisory services to accelerate global health innovation

Growth Strategy & Capital Formation

Growth Strategy & Capital Formation

Our Services

Cereona Partners is uniquely positioned to liaise between investors, shareholders, and management.

We customize our services to meet your needs.

  • End-to-end finance and capital strategy

    • Strategic forecasting and analysis

    • Financial modeling

    • Deal structuring

    Learn More

  • Narrative, numbers, & network

    • Pitch deck development

    • Fundraising process advisory

    • Warm investor network

    Learn More

  • Design and close the right deals

    • Opportunity sourcing

    • Talent strategy

    • Diligence support

    Learn More

Work With Us

Client Results

  • "Cereona's network and experience across the healthcare industry is quite extensive. They deeply understand the success factors to scale healthcare businesses and can attract the best partners to help in doing so."

    -- Rohit Seth, Founder & Managing Director, Outcomes Collective Growth Capital 

  • “Cereona Partners supports our portfolio with sharp strategic insights—connecting us with aligned partners who add real value. They operate like part of the team.”

    -- Kunal Kain, Founder & Managing Partner, Kain Capital

  • “Cereona Partners was instrumental in helping us exceed our fundraising goals and close an oversubscribed Series B with top-tier investors. This wouldn't have been possible without their industry knowledge, strategic approach, and conviction."

    — CEO, Digital Therapeutics Company

  • "Cereona Partners consistently opens doors to high-quality investors and opportunities across the healthcare ecosystem. Their network, judgment, and diligence expertise make them a trusted partner in every deal.”

    -- Partner, Healthcare Growth Capital Fund

Recent Transactions

Affect Therapeutics

Value: $26m Series B Fundraise
Announced: July 2025

Advisor to Affect Therapeutics on its new Series B investment led by Allumia Ventures, with participation from existing investors Artis Ventures, City Light Capital, and LifeArc Ventures, and new investor Limitless Ventures

Homethrive

Value: $20m+ Series C Fundraise
Announced: November 2024

Investor in Series C round led by TELUS Global Ventures and 7Wire Ventures, with participation from Pitango HealthTech, Human Capital, Outcomes Collective Growth Capital, Allianz, The K Fund, and other family offices.

Insights

Featured
From Sick Care to Smart Care: Aligning Incentives for Prevention
From Sick Care to Smart Care: Aligning Incentives for Prevention

Today roughly 90% of healthcare spend is directed at managing symptoms. The real shift begins when payers, providers, patients and pharma all align their incentives—making early, effective care the norm, not the exception.

Read More →
Addiction Treatment is Being Redefined—and So Is the Market
Addiction Treatment is Being Redefined—and So Is the Market

Addiction is no longer just a behavioral issue, it is a chronic condition involving whole-body neurochemistry. The next generation of addiction treatment platforms must move beyond medication management.

Read More →
Navigating Healthcare AI: A Guide for Private Equity Investors
Navigating Healthcare AI: A Guide for Private Equity Investors

As healthcare expenditure continues to surge, AI can address challenges across the healthcare continuum.

Read More →

About Cereona Partners

Cereona Partners provides strategic capital formation and advisory services for growth stage healthcare companies.

We are partners who have sat in every seat—founder, funder, and builder. Our firm engineers “win-win” outcomes by clarifying incentives, de-risking narratives with evidence, and structuring processes that respect the realities of founders, boards, and sophisticated capital.

Our name combines Ceres—the Roman goddess of human flourishing—with corona, the sun’s halo revealed during an eclipse.

The name reflects our mission: illuminate what others may not see and back transformative ideas that advance human flourishing and planetary health.

Team

Opal Joshi

  • Founder & CEO

    Opal Joshi is the Founder and CEO of Cereona Partners. She is a healthcare industry insider who has built companies, underwritten risk, and executed complex transactions, giving her a full-stack view of how outcomes are actually created.

    Cereona Partners is her answer to bring a new approach to dealmaking: tech-native, rigorously prepared, and designed for innovation.

    Past Experience

    • Leerink Partners – Head of Middle Market Sponsor Coverage

    • Novo Holdings – Private equity, pharma services and healthcare technology

    • Formation Bio – In-licensing and business development

    • Flatiron Health – Strategic partnerships and JVs

    • Roivant Sciences – In-licensing and commercial development

    Email

Contact Us